| Literature DB >> 25358362 |
Shiyan Sui1, Yimin Jia2, Bin He2, Runsheng Li2, Xian Li2, Demin Cai2, Haogang Song2, Rongkui Zhang3, Ruqian Zhao2.
Abstract
Maternal malnutrition during pregnancy may give rise to female offspring with disrupted ovary functions in adult age. Neonatal ovary development predisposes adult ovary function, yet the effect of maternal nutrition on the neonatal ovary has not been described. Therefore, here we show the impact of maternal protein restriction on the expression of folliculogenic and steroidogenic genes, their regulatory microRNAs and promoter DNA methylation in the ovary of neonatal piglets. Sows were fed either standard-protein (SP, 15% crude protein) or low-protein (LP, 7.5% crude protein) diets throughout gestation. Female piglets born to LP sows showed significantly decreased ovary weight relative to body weight (p<0.05) at birth, which was accompanied with an increased serum estradiol level (p<0.05). The LP piglets demonstrated higher ratio of bcl-2 associated X protein/B cell lymphoma/leukemia-2 mRNA (p<0.01), which was associated with up-regulated mRNA expression of bone morphogenic protein 4 (BMP4) (p<0.05) and proliferating cell nuclear antigen (PCNA) (p<0.05). The steroidogenic gene, cytochrome P450 aromatase (CYP19A1) was significantly down-regulated (p<0.05) in LP piglets. The alterations in ovarian gene expression were associated with a significant down-regulation of follicle-stimulating hormone receptor mRNA expression (p<0.05) in LP piglets. Moreover, three microRNAs, including miR-423-5p targeting both CYP19A1 and PCNA, miR-378 targeting CYP19A1 and miR-210 targeting BMP4, were significantly down-regulated (p<0.05) in the ovary of LP piglets. These results suggest that microRNAs are involved in mediating the effect of maternal protein restriction on ovarian function through regulating the expression of folliculogenic and steroidogenic genes in newborn piglets.Entities:
Keywords: Folliculogenesis; Maternal Dietary Protein; MicroRNA; Neonatal Piglet; Ovary; Steroidogenesis
Year: 2014 PMID: 25358362 PMCID: PMC4213680 DOI: 10.5713/ajas.2014.14335
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Ingredients and calculated composition of the experimental diets
| Items | Standard protein | Low-protein |
|---|---|---|
| Ingredient (g/kg) | ||
| Corn | 370 | 615 |
| Wheat | 300 | 100 |
| Bran | 80 | 100 |
| Soybean Meal | 170 | 0 |
| Maize starch | 0 | 100 |
| Lignocellulose | 30 | 40 |
| CaHPO4 | 20 | 25 |
| Soybean oil | 10 | 0 |
| Premix | 20 | 20 |
| Calculated composition | ||
| Digestible energy (MJ/kg) | 13.10 | 13.10 |
| Crude protein (%) | 15 | 7.50 |
| Crude fiber (%) | 4.50 | 4.30 |
| Calcium (%) | 0.84 | 0.85 |
| Phosphorous (%) | 0.65 | 0.61 |
The premix contains (per kilogram): retinol: 1,100 kIU; cholecalciferol, 350 kIU; vitamin K3, 0.4 g; vitamin B1, 0.4 g; vitamin B2, 1,640 mg; vitamin B6, 0.65 g; vitamin B12, 4.4 mg; lysine, 72 g; niacin, 4.5 g; pantothenic acid, 2.5 g; d-pantothenic acid, 2 g; folic acid, 5.2 g; biotin, 30 mg; d-biotin, 16 mg; choline chloride, 30 g; vitamin C, 20 g; manganese, 0.8 g; zinc, 7 g; ferrous, 7 g; copper, 2 g; selenium, 20 mg; sodium chloride, 3 g; β-xylanase, 8,000 kIU; antioxidant, 0.19 g; acidifier, 2.5 g.
Nucleotide sequences of specific primers
| Gene name | Products (bp) | Primer sequences (5′ to 3′) | GenBank accession number |
|---|---|---|---|
| 122 | F: CCCACGGAATCGAGAAAGAG | AY265350.1 | |
| 143 | F: TGACGGCAACTTCAACTGGG | XM_003127290.2 | |
| 142 | F: GCCTTTGTGGAGCTGTATGG | XM_003121700.2 | |
| 235 | F: TCAGAGCCACTGTGGTTTATCG | NM_001005155.1 | |
| 172 | F: GGGCTCGGAAGAAGAATAAGA | NM_001101031.2 | |
| 90 | F: GGTTCAGGCTCTGTTGTGGTGT | XM_003359883.1 | |
| 145 | F: CACTGACCTGGGCTGATGAC | NM_001004049.1 | |
| 196 | F: TCGAGCAGACGTTCCTTGAG | NM_001128472.1 | |
| 187 | F: GCTGCTCATTGGCTTAC | NM_214431.1 | |
| 136 | F: TCCAAGCCAAGACGAAC | NM_214428.1 | |
| 149 | F: GGCTCCAGAGGCCATAAAGA | X13768.1 | |
| 202 | F: GACTTTGTGAGTGTCGGCTGTA | U53020.1 | |
| 152 | F: TCACAGTCCCTCGGTTCCTT | NM_214386.2 | |
| 255 | F: ATGGGGCTCTACCTGCTACTCA | NM_214449.1 | |
| 151 | F: ATGAAGTGCAAGAACGTGGTG | NM_214220.1 | |
| 191 | F: GCCCTGTTACCAGTCCAAGTT | NM_001001533.1 |
F, forward; R, reverse; BAX, bcl-2 associated X protein; Bcl-2, B cell lymphoma/leukemia-2; BMP, bone morphogenic protein; PCNA, proliferating cell nuclear antigen; βHSD, β-hydroxysteroid dehydrogenase; CYP19A1, cytochrome P450 aromatase; CYP17A1, cytochrome P450 17a-hydroxylase; CYP11A1, cytochrome P450 cholesterol side-chain cleavage enzyme; StAR, steroidogenic acute regulatory protein; FSHR, follicle-stimulating hormone receptor; LHR, luteinizing hormone receptor; ER, estrogen receptor α.
The primer sequences of miRNAs expression
| Name | Primer sequences (5′ to 3′) | miRbase accession |
|---|---|---|
| miR-378 | ACTGGACTTGGAGTCAGAAGGC | MIMAT0013868 |
| miR-98 | TGAGGTAGTAAGTTGTATTGTT | MIMAT0013905 |
| miR -let-7d-5p | AGAGGTAGTAGGTTGCATAGTT | MIMAT0025356 |
| miR-140-5p | AGTGGTTTTACCCTATGGTAG | MIMAT0002143 |
| miR-140-3p | TACCACAGGGTAGAACCACGGAC | MIMAT0013881 |
| miR-let-7c | TGAGGTAGTAGGTTGTATGGTT | MIMAT0002151 |
| miR-423-5p | TGAGGGGCAGAGAGCGAGACTTT | MIMAT0013880 |
| miR-423-3p | AGCTCGGTCTGAGGCCCCTCAGT | MIMAT0013881 |
| miR-17-5p | CAAAGTGCTTACAGTGCAGGTAG | MIMAT0007755 |
| miR-17-3p | ACTGCAGTGAAGGCACTTGTAG | MIMAT0015268 |
| miR-885-3p | AGGCAGCGGGGTGTAGTGGAT | MIMAT0013903 |
| miR-421-5p | CCTCATTAAATGTTTGTTGAATGA | MIMAT0017970 |
| miR-18a | TAAGGTGCATCTAGTGCAGATA | MIMAT0002161 |
| miR-122 | TGGAGTGTGACAATGGTGTTTGT | MIMAT0002119 |
| miR-210 | CTGTGCGTGTGACAGCGGCTGA | MIMAT0007761 |
| miR-487b | GTGGTTATCCCTGTCCTGTTCG | MIMAT0017973 |
| U6 snRNA | GGCAAGGATGACACGCAAAT | ENSSSCT00000019750 |
| poly(T) adapter | TAGAGTGAGTGTAGCGAGCACAGAATTAATACGACTCACTATAGGTTTTTTTTTTTTTTTTVN | |
| universal primer | TAGAGTGAGTGTAGCGAGCA |
The primer sequences of MeDIP analysis
| Name | Primer sequences (5′ to 3′) |
|---|---|
| BMP4 CpG1 | F: AACTGGGAACAGGCTTAGGAA |
| BMP4 CpG2 | F: GACCTGCCTTCCAGAGTCCA |
| PCNA CpG | F: CCGCATCTGCAACCTATACCA |
| CYP19A1 CpG | F: ATCGTGGAGCAGTGGTTA |
| mc1 | F: CCCTATAACGCCTTGCCAAACC |
MeDIP, methylated DNA immunoprecipitation; F, forward; R, reverse; BMP, bone morphogenic protein; PCNA, proliferating cell nuclear antigen; CYP19A1, cytochrome P450 aromatase; mc1, methylation control 1.
Body weight, ovary weight and serum concentrations of sex steroid hormones in neonatal piglets
| Parameter | SP | LP | p value |
|---|---|---|---|
| BW (kg) | 1.49±0.08 | 1.57±0.04 | 0.40 |
| OW (g) | 0.11±0.01 | 0.08±0.01 | 0.07 |
| OW/BW (g/kg) | 0.08±0.01 | 0.05±0.01 | 0.03 |
| E2 (pg/mL) | 6.42±2.12 | 38.33±17.57 | 0.04 |
| P4 (ng/mL) | 9.10±1.42 | 13.56±2.94 | 0.16 |
| T (ng/mL) | 0.42±0.38 | 1.16±0.68 | 0.33 |
SP, standard protein; LP, low-protein; BW, body weight; OW, ovary weight; E2, 17β-estradiol; P4, progesterone; T, testosterone; SEM, standard error of the mean.
Values are mean±SEM, statistical significances were set at p<0.05.
Figure 1Ovarian expression of folliculogenic and steroidogenic genes in neonatal piglets. A, folliculogenic genes expression; B, steroidogenic genes expression. Data are expressed as mean±standard error of the mean. Asterisks indicate statistically significant differences (p<0.05), n = 8.
Figure 2DNA methylation analysis in the CpG islands of BMP4, PCNA, and CYP19A1 promoter. The CpG islands in the promoter of each gene are presented above the bargraphs of respective MeDIP analysis. A, CpG islands of BMP4 promoter and MeDIP analysis; B, CpG island of PCNA promoter and MeDIP analysis; C, CpG island of CYP19A1 promoter and MeDIP analysis. Data are expressed as mean±standard error of the mean. Asterisks indicate statistically significant differences (p<0.05), n = 8. CpG, cytosine phosphate guanine; BMP4, bone morphogenic protein 4; PCNA, proliferating cell nuclear antigen; CYP19A1, cytochrome P450 aromatase; MeDIP, methylated DNA immunoprecipitation.
Figure 3Ovarian expression of miRNAs predicted to target A, BMP4; B, FSHR; C, PCNA; and D, CYP19A1 genes in neonatal piglets. Predicted binding sites of miRNAs on each target gene are presented above the bargraphs of respective miRNA expression. Data are expressed as mean±standard error of the mean. Asterisks indicate statistically significant differences (p<0.05), n = 8. BMP4, bone morphogenic protein 4; FSHR, follicle-stimulating hormone receptor; PCNA, proliferating cell nuclear antigen; CYP19A1, cytochrome P450 aromatase.